BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6091968)

  • 1. Indications for surgical treatment of Parkinson's disease after levodopa therapy.
    van Manen J; Speelman JD; Tans RJ
    Clin Neurol Neurosurg; 1984; 86(3):207-18. PubMed ID: 6091968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor.
    Jankovic J; Cardoso F; Grossman RG; Hamilton WJ
    Neurosurgery; 1995 Oct; 37(4):680-6; discussion 686-7. PubMed ID: 8559296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stereotaxic surgery in Parkinson's disease. A preliminary report of 2 cases].
    Fernando Pitty L
    Rev Med Panama; 1992 May; 17(2):101-8. PubMed ID: 1620890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative therapy for movement disorders. Does thalamotomy alter the course of Parkinson's disease?
    Tasker RR
    Neurosurg Clin N Am; 1998 Apr; 9(2):375-80. PubMed ID: 9495899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of palilalia after stereotaxic thalamotomy in Parkinson's disease.
    Stracciari A; Guarino M; Cirignotta F; Pazzaglia P
    Eur Neurol; 1993; 33(3):275-6. PubMed ID: 8467853
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.
    Fox MW; Ahlskog JE; Kelly PJ
    J Neurosurg; 1991 Nov; 75(5):723-30. PubMed ID: 1919694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present role of stereotactic thalamotomy for parkinsonism. Retrospective analysis of operative results and thalamic lesions in computed tomograms.
    Miyamoto T; Bekku H; Moriyama E; Tsuchida S
    Appl Neurophysiol; 1985; 48(1-6):294-304. PubMed ID: 3915652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slight cerebellar signs in stereotactic thalamotomy and subthalamotomy for parkinsonism.
    Yasui N; Narabayashi H; Kondo T; Ohye C
    Appl Neurophysiol; 1976-1977; 39(3-4):315-20. PubMed ID: 801861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor performance in parkinsonism following stereotactic thalamotomy.
    Struppler A; Gurfinkel V; Mathis J; Max T
    Adv Neurol; 1993; 60():403-7. PubMed ID: 8420162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects on cognitive function and activities of daily living after stereotactic thalamotomy for Parkinson's disease].
    Maeshima S; Nakai K; Nakai E; Uematsu Y; Ozaki F; Terada T; Nakakita K; Itakura T; Komai N
    No Shinkei Geka; 1995 May; 23(5):417-21. PubMed ID: 7753321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotaxic thalamotomy--experiences from the levodopa era.
    Wester K; Hauglie-Hanssen E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):427-30. PubMed ID: 2191085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease.
    Lee ST; Lu CS
    J Formos Med Assoc; 1996 Dec; 95(12):943-5. PubMed ID: 9000814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism.
    Narabayashi H; Maeda T; Yokochi F
    Appl Neurophysiol; 1987; 50(1-6):330-7. PubMed ID: 3329871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between clinical outcome and size and site of the lesion in computed tomography guided thalamotomy and pallidotomy.
    Hariz MI
    Stereotact Funct Neurosurg; 1990; 54-55():172-85. PubMed ID: 2080334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of parkinson's disease--combined therapy with levodopa and thalamotomy.
    Mosso JA; Rand RW
    West J Med; 1975 Jan; 122(1):1-6. PubMed ID: 1109524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.
    Samuel M; Caputo E; Brooks DJ; Schrag A; Scaravilli T; Branston NM; Rothwell JC; Marsden CD; Thomas DG; Lees AJ; Quinn NP
    Brain; 1998 Jan; 121 ( Pt 1)():59-75. PubMed ID: 9549488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of ventrolateral thalamotomy for patients with Parkinson's disease.
    Moriyama E; Beck H; Miyamoto T
    Neurol Med Chir (Tokyo); 1999 May; 39(5):350-6; discussion 356-7. PubMed ID: 10481437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of severe Parkinson disease with electric stimulation of the subthalamic nuclei].
    Ostergaard K; Sunde NA; Sørensen JC; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5491-6. PubMed ID: 11068525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease.
    Skalabrin EJ; Laws ER; Bennett JP
    Mov Disord; 1998 Sep; 13(5):775-81. PubMed ID: 9756145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What happened to VIM thalamotomy for Parkinson's disease?
    Tasker RR; Siqueira J; Hawrylyshyn P; Organ LW
    Appl Neurophysiol; 1983; 46(1-4):68-83. PubMed ID: 6367656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.